Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma
Conditions: Gastric Adenocarcinoma; GastroEsophageal Cancer Interventions: Drug: Cabozantinib; Drug: Pembrolizumab Sponsors: University of California, Irvine; Exelixis Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Research | Study